Salpingo-Oophorectomy Procedure
Description, Latest Information and Doctors

Salpingo-Oophorectomy Overview

Save information for later
Sign Up

Learn About Salpingo-Oophorectomy

Who are the top Salpingo-Oophorectomy Local Doctors?
Steven A. Narod
Elite in Salpingo-Oophorectomy
Steven A. Narod
Elite in Salpingo-Oophorectomy
Steven A. Narod
790 Bay Street, 
Toronto, ON, CA 

Steven Narod practices in Toronto, Canada. Mr. Narod is rated as an Elite expert by MediFind in Oophorectomy. His top areas of expertise are Ovarian Cancer, Breast Cancer, BRCA Positive Breast Cancer, Oophorectomy, and Mastectomy.

Joanne Kotsopoulos
Elite in Salpingo-Oophorectomy
Joanne Kotsopoulos
Elite in Salpingo-Oophorectomy
Joanne Kotsopoulos
76 Grenville St, 
Toronto, ON, CA 

Joanne Kotsopoulos practices in Toronto, Canada. Ms. Kotsopoulos is rated as an Elite expert by MediFind in Oophorectomy. Her top areas of expertise are BRCA Positive Breast Cancer, Ovarian Cancer, Breast Cancer, Oophorectomy, and Salpingo-Oophorectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Philippe Morice
Elite in Salpingo-Oophorectomy
Philippe Morice
Elite in Salpingo-Oophorectomy
Philippe Morice

Gustave Roussy

Villejuif, FR 

Philippe Morice practices in Villejuif, France. Mr. Morice is rated as an Elite expert by MediFind in Oophorectomy. His top areas of expertise are Cervical Cancer, Ovarian Cancer, Vaginal Cancer, Hysterectomy, and Lymphadenectomy.

View All Doctors
What are the latest Salpingo-Oophorectomy Clinical Trials?
A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)
A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25 (OFSET)
Enrollment Status: Recruiting
Publish Date: February 03, 2026
Intervention Type: Drug
Study Phase: Phase 3

Summary: This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Energy-based Opportunistic Salpingo-oophorectomy During Vaginal Hysterectomy - is it Better Than Conventional Knot-and-cut Approach? A Randomized Controlled Study
Energy-based Opportunistic Salpingo-oophorectomy During Vaginal Hysterectomy - is it Better Than Conventional Knot-and-cut Approach? A Randomized Controlled Study
Enrollment Status: Recruiting
Publish Date: January 30, 2026
Intervention Type: Procedure, Device
Study Phase: Not Applicable

Summary: This study compares two methods for removing the fallopian tubes and ovaries during vaginal hysterectomy for pelvic organ prolapse. One method uses an energy-based surgical device called LigaSure Maryland, which seals blood vessels using electrical energy. The other method is the standard surgical approach, which involves clamping, cutting, and suturing the tissue. The purpose of the study is to d...

View All Clinical Trials